These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 34869564)

  • 1. Treatment and Outcome of Metastatic Renal Cell Carcinoma With Sarcomatoid Differentiation: A Single-Center, Real-World Analysis of Retrospective Data.
    Janisch F; Kienapfel C; Fühner C; Klotzbücher T; Marks P; Hillemacher T; Meyer CP; Iwata T; Parizi MK; Sauter G; Fisch M; Shariat SF; Dahlem R; Rink M
    Front Surg; 2021; 8():763271. PubMed ID: 34869564
    [No Abstract]   [Full Text] [Related]  

  • 2. Real-world evidence on first-line treatment for metastatic renal cell carcinoma with non-clear cell and sarcomatoid histologies: are sunitinib and pazopanib interchangeable?
    Bonadioa RC; Velho PI; Marta GN; Nardo M; Souza MC; Muniz DQ; Bezerra RO; Bispo RK; Faraj SF; Bastos DA; Dzik C
    Ecancermedicalscience; 2019; 13():973. PubMed ID: 31921344
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The impact of cytoreductive nephrectomy on survival outcomes in patients treated with tyrosine kinase inhibitors for metastatic renal cell carcinoma in a real-world cohort.
    Janisch F; Hillemacher T; Fuehner C; D'Andrea D; Meyer CP; Klotzbücher T; Kienapfel C; Vetterlein MW; Kimura S; Abufaraj M; Dahlem R; Shariat SF; Fisch M; Rink M
    Urol Oncol; 2020 Sep; 38(9):739.e9-739.e15. PubMed ID: 32576526
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dissecting Outcomes: Should Cytoreductive Nephrectomy Be Performed for Patients With Metastatic Renal Cell Carcinoma With Sarcomatoid Dedifferentiation?
    Adashek JJ; Zhang Y; Skelton WP; Bilotta A; Chahoud J; Zemp L; Li J; Dhillon J; Manley B; Spiess PE
    Front Oncol; 2020; 10():627025. PubMed ID: 33643921
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Outcome of patients with metastatic sarcomatoid renal cell carcinoma: results from the International Metastatic Renal Cell Carcinoma Database Consortium.
    Kyriakopoulos CE; Chittoria N; Choueiri TK; Kroeger N; Lee JL; Srinivas S; Knox JJ; Bjarnason GA; Ernst SD; Wood LA; Vaishampayan UN; Agarwal N; Pal SK; Kanesvaran R; Rha SY; Yuasa T; Donskov F; North SA; Heng DY; Rini BI
    Clin Genitourin Cancer; 2015 Apr; 13(2):e79-85. PubMed ID: 25450036
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical features and response to immune combinations in patients with renal cell carcinoma and sarcomatoid de-differentiation (ARON-1 study).
    Ciccarese C; Büttner T; Cerbone L; Zampiva I; Monteiro FSM; Basso U; Pichler M; Vitale MG; Fiala O; Roviello G; Kopp RM; Carrozza F; Pichler R; Grillone F; Calabuig EP; Zeppellini A; Küronya Z; Galli L; Facchini G; Sunela K; Mosca A; Molina-Cerrillo J; Spinelli GP; Ansari J; Scala A; Mollica V; Grande E; Buti S; Kanesvaran R; Zakopoulou R; Bamias A; Rizzo M; Massari F; Iacovelli R; Santoni M
    Int J Cancer; 2024 Dec; 155(11):2036-2046. PubMed ID: 39243397
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatments, Outcomes, and Validity of Prognostic Scores in Patients With Sarcomatoid Renal Cell Carcinoma: A 20-Year Single-Institution Experience.
    Korenbaum C; Pierard L; Thiéry A; Story F; Lindner V; Lang H; Kurtz JE; Barthélémy P
    Clin Genitourin Cancer; 2018 Jun; 16(3):e577-e586. PubMed ID: 29395949
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Presence of sarcomatoid differentiation as a prognostic indicator for survival in surgically treated metastatic renal cell carcinoma.
    Gu L; Li H; Wang H; Ma X; Wang L; Chen L; Zhao W; Zhang Y; Zhang X
    J Cancer Res Clin Oncol; 2017 Mar; 143(3):499-508. PubMed ID: 27844145
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Role of Cytoreductive Nephrectomy for Sarcomatoid Renal Cell Carcinoma: A 29-Year Institutional Experience.
    Silagy AW; Mano R; Blum KA; DiNatale RG; Marcon J; Tickoo SK; Reznik E; Coleman JA; Russo P; Hakimi AA
    Urology; 2020 Feb; 136():169-175. PubMed ID: 31726184
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Role of Cytoreductive Nephrectomy and Targeted Therapy on Outcomes of Patients With Metastatic Sarcomatoid Renal Cell Carcinoma: A Population-Based Analysis.
    Al-Juhaishi T; Deng X; Bandyopadhyay D; Paul A
    Cureus; 2022 May; 14(5):e25395. PubMed ID: 35774668
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy and Safety of Nivolumab Plus Ipilimumab versus Sunitinib in First-line Treatment of Patients with Advanced Sarcomatoid Renal Cell Carcinoma.
    Tannir NM; Signoretti S; Choueiri TK; McDermott DF; Motzer RJ; Flaifel A; Pignon JC; Ficial M; Frontera OA; George S; Powles T; Donskov F; Harrison MR; Barthélémy P; Tykodi SS; Kocsis J; Ravaud A; Rodriguez-Cid JR; Pal SK; Murad AM; Ishii Y; Saggi SS; McHenry MB; Rini BI
    Clin Cancer Res; 2021 Jan; 27(1):78-86. PubMed ID: 32873572
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Localised non-metastatic sarcomatoid renal cell carcinoma: a 31-year externally verified study.
    Blum KA; Silagy AW; Knezevic A; Weng S; Wang A; Mano R; Marcon J; DiNatale RG; Sanchez A; Tickoo S; Gupta S; Motzer R; Haas NB; Kim SE; Uzzo RG; Coleman JA; Hakimi AA; Russo P
    BJU Int; 2024 Feb; 133(2):169-178. PubMed ID: 37589200
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of tyrosine kinase inhibitors in the treatment of metastatic renal cell carcinoma with rhabdoid and sarcomatoid differentiations.
    Wang K; Duan P; Chen X; Yang Q; Feng G; Diao L; Zhang Z; Yao X
    Cancer Med; 2023 Jul; 12(13):14149-14156. PubMed ID: 37325945
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Comparison of efficacy between sorafenib and sunitinib as first-line therapy for metastatic renal cell carcinoma and analyze prognostic factors for survival].
    Cai W; Yuan YC; Li MY; Kong W; Dong BJ; Chen YH; Zhang J; Xue W; Huang YR; Zhou LX; Huang JW
    Zhonghua Zhong Liu Za Zhi; 2018 May; 40(5):384-389. PubMed ID: 29860767
    [No Abstract]   [Full Text] [Related]  

  • 15. Outcomes Associated with First-Line anti-PD-1/ PD-L1 agents vs. Sunitinib in Patients with Sarcomatoid Renal Cell Carcinoma: A Systematic Review and Meta-Analysis.
    Buonerba C; Dolce P; Iaccarino S; Scafuri L; Verde A; Costabile F; Pagliuca M; Morra R; Riccio V; Ribera D; De Placido P; Romeo V; Crocetto F; Longo N; Imbimbo C; De Placido S; Di Lorenzo G
    Cancers (Basel); 2020 Feb; 12(2):. PubMed ID: 32050629
    [No Abstract]   [Full Text] [Related]  

  • 16. Significance of preoperative prognostic nutrition index as prognostic predictors in patients with metastatic renal cell carcinoma with tyrosine kinase inhibitors as first-line target therapy.
    Cai W; Zhong H; Kong W; Dong B; Chen Y; Zhou L; Xue W; Huang Y; Zhang J; Huang J
    Int Urol Nephrol; 2017 Nov; 49(11):1955-1963. PubMed ID: 28889323
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Real World Overall Survival of Patients With Metastatic Renal Cell Carcinoma Treated With Only Available Sunitinib and Pazopanib in First-Line Setting.
    Nikic P; Babovic N; Dzamic Z; Salma S; Stojanovic V; Matkovic S; Pejcic Z; Juskic K; Soldatovic I
    Front Oncol; 2022; 12():892156. PubMed ID: 35756652
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic significance of sarcomatoid features in metastatic renal cell carcinoma treated with cytoreductive nephrectomy and targeted therapy.
    Cortese BD; Chelluri R; Xia L; Ostrowski DA; Roberson DS; Strother M; Ding JM; Schwartz L; Lee DJ; Guzzo TJ
    Am J Clin Exp Urol; 2022; 10(5):327-333. PubMed ID: 36313210
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Metastatic Renal Cell Carcinoma Rapidly Progressive to Sunitinib: What to Do Next?
    Bersanelli M; Iacovelli R; Buti S; Houede N; Laguerre B; Procopio G; Lheureux S; Fischer R; Negrier S; Ravaud A; Oudard S; Escudier B; Albiges L; Porta C
    Eur Urol Oncol; 2021 Apr; 4(2):274-281. PubMed ID: 31331862
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High-dose interleukin 2 in patients with metastatic renal cell carcinoma with sarcomatoid features.
    Achkar T; Arjunan A; Wang H; Saul M; Davar D; Appleman LJ; Friedland D; Parikh RA
    PLoS One; 2017; 12(12):e0190084. PubMed ID: 29261796
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.